These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14624209)

  • 21. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clozapine-induced obsessive-compulsive disorder: a case report].
    Sánchez Bonome L; Barjau Romero JM; Lara Muñoz Rd; Márquez Tejero MC
    Actas Esp Psiquiatr; 2002; 30(5):330-4. PubMed ID: 12372230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone may worsen fluoxetine-treated OCD.
    Andrade C
    J Clin Psychiatry; 1998 May; 59(5):255-6. PubMed ID: 9632039
    [No Abstract]   [Full Text] [Related]  

  • 25. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics.
    Lim M; Park DY; Kwon JS; Joo YH; Hong KS
    J Clin Psychopharmacol; 2007 Dec; 27(6):712-3. PubMed ID: 18004145
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone-induced obsessive-compulsive symptoms in two children.
    Duggal HS
    J Child Adolesc Psychopharmacol; 2004; 14(1):155-6. PubMed ID: 15142405
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone-induced thrombocytopenia: a case report.
    Semba J; Okui S
    Gen Hosp Psychiatry; 2009; 31(1):97-8. PubMed ID: 19134517
    [No Abstract]   [Full Text] [Related]  

  • 30. [Iatrogenic devil-obsession: a complication of overdosage of neuroleptics].
    Cullberg J; Cederberg K
    Lakartidningen; 1991 May; 88(20):1868-9. PubMed ID: 1675704
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting risperidone-induced periorbital edema.
    Pelizza L
    J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
    Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
    J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychiatric treatment of patients predisposed to priapism induced by quetapine, trazadone and risperidone: a case report.
    Rosenberg I; Aniskin D; Bernay L
    Gen Hosp Psychiatry; 2009; 31(1):98. PubMed ID: 19134518
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of risperidone on prolactinoma--a case report.
    Mendhekar DN; Jiloha RC; Srivastava PK
    Pharmacopsychiatry; 2004 Jan; 37(1):41-2. PubMed ID: 14750048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.